Search bioRxiv⌕ Search

Biology subjects

Zavileyskiy, L.

Publications and source records attributed to Zavileyskiy, L..

2 recordsLinked to original sources

Estimation of splicing metrics for NMD-sensitive transcripts

Alternative splicing is commonly quantified using the Percent-Spliced-In (PSI) metric, which measures the relative abundances of alternatively spliced isoforms. However, some transcript isoforms are targeted by the nonsense-mediated decay (NMD) pathway, introducing a strong bias that leads to underestimation of their true splicing rates. To correct for this bias, we developed an analytical framework and a set of statistical models employing a linear fractional transformation depending on a single parameter capturing the degradation rate of NMD-sensitive transcripts relative to normal mRNA decay. Using Gaussian mixture models, we demonstrated a clear separation of splicing events into two classes, responders and non-responders, with the former exhibiting strong upregulation upon NMD inhibition and the latter showing little or no response. Moreover, non-responders displayed higher coding potential and stronger translation signals both upstream and downstream of the stop codon, which are characteristic of NMD escape through translational readthrough. We further showed that incorporation of event-specific relative decay rates improves the interpretation of differential splicing patterns for NMD-sensitive transcripts. In sum, our results provide a solid framework for unbiased estimation of splicing metrics in NMD-sensitive transcripts from short-read RNA-seq data, without requiring NMD inhibition experiments.

bioinformatics↗

Global changes in unproductive splicing and the NMD system efficiency in tumors

The Nonsense-Mediated Decay (NMD) pathway is a mRNA quality control mechanism, which not only degrades deleterious transcripts but also orchestrates a large number of post-transcriptional regulatory programs through unproductive splicing. Here, we developed a robust metric derived from the quantification of splicing in the RNA-seq data to measure NMD efficiency at a sample level. We demonstrate that NMD efficiency varies substantially both between and within tissues, with the magnitude of variation comparable to that observed upon knockdown of the core NMD factor UPF1. By analyzing TCGA cancer cohorts, we further show that, in many tumors, unproductive splicing events exhibit coordinated changes towards either collective suppression or collective activation of NMD isoforms, which is indicative of a global deregulation of the NMD pathway activity. Consistently, we observed a striking divergence of NMD efficiency in cancers from the tissue-specific baseline level suggesting that tumors partially erase the NMD signature of their tissue of origin. The application of the developed metric to RNA-binding protein knockdowns allowed identification of several novel potential regulators of NMD efficiency. In sum, this study provides a solid framework for NMD efficiency quantification, describes its biological and clinical relevance, and opens new avenues for dissecting mechanisms of post-transcriptional gene expression regulation by the NMD pathway.

bioinformatics↗